Added to YB: 2025-05-09
Pitch date: 2025-03-24
MRVI [bullish]
Maravai LifeSciences Holdings, Inc.
-8%
current return
Author Info
No bio for this author
Company Info
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
Market Cap
$305.2M
Pitch Price
$2.25
Price Target
N/A
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
growth
Maravai LifeSciences Holdings, Inc. - $MRVI
MRVI: Buy quality biz at 3x '25 revenue with free pipeline optionality. Base business worth entire $550M EV, generates 45-50% EBITDA margins. CleanCap tech in 30% of 447 mRNA/gene trials. Pipeline could add $600M annual rev long-term. GTCR (40-50% owner) potentially positioning for take-private. New FDA approvals = catalysts.
Read full article (12 min)